{"nctId":"NCT04738279","briefTitle":"The CASCADE HF Soft Launch and Calibration Phase I and II","startDateStruct":{"date":"2020-12-14","type":"ACTUAL"},"conditions":["Heart Failure"],"count":20,"armGroups":[{"label":"Phase I: Soft Launch (120 days)","type":"EXPERIMENTAL","interventionNames":["Device: Non-Invasive Continuous Remote Patient Monitoring","Other: Affective Analysis of Participant Response to Continuous Remote Patient Monitoring"]},{"label":"Phase II: Calibration (210 days)","type":"EXPERIMENTAL","interventionNames":["Device: Non-Invasive Continuous Remote Patient Monitoring","Other: Affective Analysis of Participant Response to Continuous Remote Patient Monitoring"]}],"interventions":[{"name":"Non-Invasive Continuous Remote Patient Monitoring","otherNames":[]},{"name":"Affective Analysis of Participant Response to Continuous Remote Patient Monitoring","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient is an inpatient at NorthShore University HealthSystem\n* Patient is on the heart failure consult list\n* Patient has a history of heart failure\n* Patient received at least one dose of IV diuretics at index hospitalization\n* Patient is discharging with NorthShore Home Health services\n* Symptoms corresponding to New York Heart Association function class II-IV\n* Patient has heart failure with reduced left ventricular ejection fraction (LVEF)\\<40%, or HF with mid-ranged ejection fraction (LVEF 40-50%), or HF with preserved ejection fraction (LVEFâ‰¥50%)\n* Patient is in the top 50% risk of readmission across NorthShore University HealthSystem's CAPE 30-day readmission model\n* Patient is at least 18 years of age\n* Patient is fluent in English\n* Patient agrees to protocol-required procedures\n\nExclusion Criteria:\n\n* Patient has cognitive or physical limitations that, in the opinion of the investigator, limit the patient's ability to maintain patch, phone\n* Patient has allergy to hydrocolloid adhesives\n* Patient has present skin damage preventing them from wearing a study device\n* Patient has renal dysfunction requiring dialysis\n* Pregnancy","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Attrition Rate","description":"Drop out from study","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"PRIMARY","title":"Enrollment Rate","description":"Enrollment rate for entire patient cohort","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"15","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Diuretic Escalation","description":"Frequency of augmenting diuretic dosage as prescribed by the cardiologist to the patient.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"9","spread":null}]}]}]},{"type":"SECONDARY","title":"30-day Readmission","description":"30-day readmission to hospital","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":5},"commonTop":[]}}}